Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000218 · ClinicalTrials.gov registry record · Phase 4
Pharmacotherapy and Intensive Treatment - 2
A Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 4
- Development phase
- 353
- Enrollment target
NCT00000218: Completed Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00000218 is a Phase 4 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 353 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000218, a Phase 4 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 353 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
Interventions
- DRUG Carbamazepine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 353 participants |
| Est. Completion | 2005-06 |
| Phase | Phase 4 |
What the finished NCT00000218 record still lists
NCT00000218 is an interventional study that assigns participants to a tested intervention. The registered 353 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 1 intervention - of which Carbamazepine is the first listed.
NCT00000218 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000218 about?
NCT00000218 is a clinical study titled "Pharmacotherapy and Intensive Treatment - 2". The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
What is the current status of trial NCT00000218?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 353 participants. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00000218?
The interventions under investigation include: Carbamazepine (DRUG).
Who is sponsoring clinical trial NCT00000218?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000218's enrollment target sits among peer trials
353 229th of 2000 higher than 1,772 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05548296 · 353 participants · Phase 2
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- NCT05884775 · 353 participants · NA
Novel Digital Patient-Reported Outcomes Tool for Diabetes Management
- NCT02579967 · 354 participants · Phase 2
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- NCT02610413 · 354 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer